Clinical Trial Update: Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial [EARLY_Phase 1]

View source ↗

Summary

This document reports the termination of a Phase 0/early Phase 1 trial evaluating repurposed posaconazole for glioblastoma, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioblastoma Multiforme

Drugs mentioned

• Posaconazole (Noxafil) (posaconazole)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Glioblastoma, Glioblastoma Multiforme | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2025-12-17